Figure 1.
(a) Baseline SD-OCT image of neovascular AMD with SHRM (green asterisk) above RPE (b) Partial resolution of SHRM at 3 months after anti-VEGF therapy (c) Complete resolution of SHRM at 12-follow-up. (d) Baseline SD-OCT image of neovascular AMD with fibrovascular PED (green arrow) without SHRM (e) Partial resolution of SRF at 3 months after anti-VEGF therapy (f) Complete resolution of SRF with persistence of FVPED at 12-follow-up
